Assessment of combinations of antiandrogenic compounds vinclozolin and flutamide in a yeast based reporter assay

Regulatory Toxicology and Pharmacology

Volumn 60, Issue 3, 2011, Pages 373-380

  Kolle, Susanne N ^a   Melching Kollmuss, Stephanie ^a   Krennrich, Gerhard ^a   Landsiedel, Robert ^a   van Ravenzwaay, Bennard ^a  

^a BASF SE   (Germany)

Author keywords

Antiandrogen; Combination; Disruptor; Endocrine; Flutamide; Vinclozolin; Yeast

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; ANDROGEN RECEPTOR; CHLORPHENOTANE; FLUTAMIDE; MIFEPRISTONE; PROCYMIDONE; VINCLOZOLIN;

ANTIANDROGEN THERAPY; ARTICLE; COMBINATION CHEMOTHERAPY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SCREENING; ENDOCRINE FUNCTION; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY; TRANSACTIVATION;

ANDROGEN ANTAGONISTS; BIOLOGICAL ASSAY; DRUG SYNERGISM; FLUTAMIDE; HUMANS; OXAZOLES; RECEPTORS, ANDROGEN; RECOMBINANT PROTEINS; RISK ASSESSMENT; SACCHAROMYCES CEREVISIAE;

EID: 79960134974     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2011.05.005     Document Type: Article

References (63)

1. Aldridge W.N. The biological basis and measurement of thresholds. Annu. Rev. Pharmacol. Toxicol. 1986, 26:39-58.
2. Beck V., Reiter E., Jungbauer A. Androgen receptor transactivation assay using green fluorescent protein as a reporter. Anal. Biochem. 2008, 373(2):263-271.
3. Birkhoj M., Nellemann C., Jarfelt K., Jacobsen H., Andersen H.R., Dalgaard M., Vinggaard A.M. The combined antiandrogenic effects of five commonly used pesticides. Toxicol. Appl. Pharmacol. 2004, 201(1):10-20.
4. Bolt H.M., Janning P., Michna H., Degen G.H. Comparative assessment of endocrine modulators with oestrogenic activity: I. Definition of a hygiene-based margin of safety (HBMOS) for xeno-oestrogens against the background of European developments. Arch. Toxicol. 2001, 74(11):649-662.
5. Boobis A.R., Ossendorp B.C., Banasiak U., Hamey P.Y., Sebestyen I., Moretto A. Cumulative risk assessment of pesticide residues in food. Toxicol. Lett. 2008, 180(2):137-150.
6. Borgert C.J., Quill T.F., McCarty L.S., Mason A.M. Can mode of action predict mixture toxicity for risk assessment?. Toxicol. Appl. Pharmacol. 2004, 201(2):85-96.
7. Bovee T.F., Helsdingen R.J., Hamers A.R., van Duursen M.B., Nielen M.W., Hoogenboom R.L. A new highly specific and robust yeast androgen bioassay for the detection of agonists and antagonists. Anal. Bioanal. Chem. 2007, 389(5):1549-1558.
8. Charles G.D., Gennings C., Zacharewski T.R., Gollapudi B.B., Carney E.W. Assessment of interactions of diverse ternary mixtures in an estrogen receptor-alpha reporter assay. Toxicol. Appl. Pharmacol. 2002, 180(1):11-21.
9. Charles G.D., Kan H.L., Schisler M.R., Bhaskar G.B., Sue M.M. A comparison of in vitro and in vivo EDSTAC test battery results for detecting antiandrogenic activity. Toxicol. Appl. Pharmacol. 2005, 202(1):108-120.
10. Christiansen S., Scholze M., Axelstad M., Boberg J., Kortenkamp A., Hass U. Combined exposure to anti-androgens causes markedly increased frequencies of hypospadias in the rat. Int. J. Androl. 2008, 31(2):241-248.
11. Delaere K.P., Van Thillo E.L. Flutamide monotherapy as primary treatment in advanced prostatic carcinoma. Semin. Oncol. 1991, 18(5 Suppl. 6):13-18.
12. Eaton, D.L., Gilbert, S.G., 2008. Cassarett's & Doull's Toxicology the basis science of poisons. Chapter 2 Principles of Toxicology.
13. EFSA, 2009. Scientific opinion on risk assessment for a selected group of pesticides from the triazole group to test possible methodologies to assess cumulative effects from exposure through food from these pesticides on human health. EFSA J. 7(9), 1167.
14. Fent K., Escher C., Caminada D. Estrogenic activity of pharmaceuticals and pharmaceutical mixtures in a yeast reporter gene system. Reprod. Toxicol. 2006, 22(2):175-185.
15. Feron V.J., Groten J.P. Toxicological evaluation of chemical mixtures. Food Chem. Toxicol. 2002, 40(6):825-839.
16. Foster P.M., McIntyre B.S. Endocrine active agents: implications of adverse and non-adverse changes. Toxicol. Pathol. 2002, 30(1):59-65.
17. Gaido K.W., Leonard L.S., Lovell S., Gould J.C., Babai D., Portier C.J., McDonnell D.P. Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol. Appl. Pharmacol. 1997, 143(1):205-212.
18. Groten J.P., Schoen E.D., van Bladeren P.J., Kuper C.F., van Zorge J.A., Feron V.J. Subacute toxicity of a mixture of nine chemicals in rats: detecting interactive effects with a fractionated two-level factorial design. Fundam. Appl. Toxicol. 1997, 36(1):15-29.
19. Hass U., Scholze M., Christiansen S., Dalgaard M., Vinggaard A.M., Axelstad M., Metzdorff S.B., Kortenkamp A. Combined exposure to anti-androgens exacerbates disruption of sexual differentiation in the rat. Environ. Health Perspect. 2007, 115(Suppl. 1):122-128.
20. Heindel J.J., Chapin R.E., Gulati D.K., George J.D., Price C.J., Marr M.C., Myers C.B., Barnes L.H., Fail P.A., Grizzle T.B. Assessment of the reproductive and developmental toxicity of pesticide/fertilizer mixtures based on confirmed pesticide contamination in California and Iowa groundwater. Fundam. Appl. Toxicol. 1994, 22(4):605-621.
21. ICCVAM, 2002. ICCVAM Evaluation of In Vitro Test Methods For Detecting Potential Endocrine Disruptors: Estrogen Receptor and Androgen Receptor Binding and Transcriptional Activation Assays (NIH Publication No. 03-4503).
22. Imperato-McGinley J., Sanchez R.S., Spencer J.R., Yee B., Vaughan E.D. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies. Endocrinology 1992, 131(3):1149-1156.
23. Jonker D., Woutersen R.A., Feron V.J. Toxicity of mixtures of nephrotoxicants with similar or dissimilar mode of action. Food Chem. Toxicol. 1996, 34(11-12):1075-1082.
24. Jonker D., Woutersen R.A., van Bladeren P.J., Til H.P., Feron V.J. 4-week oral toxicity study of a combination of eight chemicals in rats: comparison with the toxicity of the individual compounds. Food Chem. Toxicol. 1990, 28(9):623-631.
25. Jonker D., Woutersen R.A., van Bladeren P.J., Til H.P., Feron V.J. Subacute (4-wk) oral toxicity of a combination of four nephrotoxins in rats: comparison with the toxicity of the individual compounds. Food Chem. Toxicol. 1993, 31(2):125-136.
26. Kassim N.M., McDonald S.W., Reid O., Bennett N.K., Gilmore D.P., Payne A.P. The effects of pre- and postnatal exposure to the nonsteroidal antiandrogen flutamide on testis descent and morphology in the Albino Swiss rat. J. Anat. 1997, 190(Pt. 4):577-588.
27. Kelce W.R., Gray L.E., Wilson E.M. Antiandrogens as environmental endocrine disruptors. Reprod. Fertil. Dev. 1998, 10(1):105-111.
28. Kelce W.R., Lambright C.R., Gray L.E., Roberts K.P. Vinclozolin and p,p'-DDE alter androgen-dependent gene expression: in vivo confirmation of an androgen receptor-mediated mechanism. Toxicol. Appl. Pharmacol. 1997, 142(1):192-200.
29. Kelce W.R., Monosson E., Gamcsik M.P., Laws S.C., Gray L.E. Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. Toxicol. Appl. Pharmacol. 1994, 126(2):276-285.
30. Kjaerstad M.B., Taxvig C., Andersen H.R., Nellemann C. Mixture effects of endocrine disrupting compounds in vitro. Int. J. Androl. 2010, 33(2):425-433.
31. Kolle S.N., Kamp H.G., Huener H.A., Knickel J., Verlohner A., Woitkowiak C., Landsiedel R., van R.B. In house validation of recombinant yeast estrogen and androgen receptor agonist and antagonist screening assays. Toxicol. In Vitro 2010, 24(7):2030-2040.
32. Kortenkamp, A., Backhaus, T., Faust, M., 2009. State of the Art Report on Mixture Toxicity. Study Contract Number 070307/2007/485103/ETU/D.1, 1-391.
33. Kunz P.Y., Fent K. Estrogenic activity of UV filter mixtures. Toxicol. Appl. Pharmacol. 2006, 217(1):86-99.
34. Labrie F. Mechanism of action and pure antiandrogenic properties of flutamide. Cancer 1993, 72(12 Suppl.):3816-3827.
35. Mak P., McDonnell D.P., Weigel N.L., Schrader W.T., O'Malley B.W. Expression of functional chicken oviduct progesterone receptors in yeast (Saccharomyces cerevisiae). J. Biol. Chem. 1989, 264(36):21613-21618.
36. Matsuura I., Saitoh T., Ashina M., Wako Y., Iwata H., Toyota N., Ishizuka Y., Namiki M., Hoshino N., Tsuchitani M. Evaluation of a two-generation reproduction toxicity study adding endpoints to detect endocrine disrupting activity using vinclozolin. J Toxicol. Sci. 2005, 30(Spec. No.):163-188.
37. McIntyre B.S., Barlow N.J., Foster P.M. Androgen-mediated development in male rat offspring exposed to flutamide in utero: permanence and correlation of early postnatal changes in anogenital distance and nipple retention with malformations in androgen-dependent tissues. Toxicol. Sci. 2001, 62(2):236-249.
38. Metzdorff S.B., Dalgaard M., Christiansen S., Axelstad M., Hass U., Kiersgaard M.K., Scholze M., Kortenkamp A., Vinggaard A.M. Dysgenesis and histological changes of genitals and perturbations of gene expression in male rats after in utero exposure to antiandrogen mixtures. Toxicol. Sci. 2007, 98(1):87-98.
39. Metzger D., White J.H., Chambon P. The human oestrogen receptor functions in yeast. Nature 1988, 334(6177):31-36.
40. Murphy W.M., Soloway M.S., Barrows G.H. Pathologic changes associated with androgen deprivation therapy for prostate cancer. Cancer 1991, 68(4):821-828.
41. Nellemann C., Dalgaard M., Lam H.R., Vinggaard A.M. The combined effects of vinclozolin and procymidone do not deviate from expected additivity in vitro and in vivo. Toxicol. Sci. 2003, 71(2):251-262.
42. Payne J., Rajapakse N., Wilkins M., Kortenkamp A. Prediction and assessment of the effects of mixtures of four xenoestrogens. Environ. Health Perspect. 2000, 108(10):983-987.
43. Payne J., Scholze M., Kortenkamp A. Mixtures of four organochlorines enhance human breast cancer cell proliferation. Environ. Health Perspect. 2001, 109(4):391-397.
44. Purvis I.J., Chotai D., Dykes C.W., Lubahn D.B., French F.S., Wilson E.M., Hobden A.N. An androgen-inducible expression system for Saccharomyces cerevisiae. Gene 1991, 106(1):35-42.
45. R Development Core Team, 2009. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria.
46. Rajapakse N., Silva E., Kortenkamp A. Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action. Environ. Health Perspect. 2002, 110(9):917-921.
47. Reffstrup T.K., Larsen J.C., Meyer O. Risk assessment of mixtures of pesticides. Current approaches and future strategies. Regul. Toxicol. Pharmacol. 2010, 56(2):174-192.
48. Rempel M.A., Schlenk D. Effects of environmental estrogens and antiandrogens on endocrine function, gene regulation, and health in fish. Int. Rev. Cell Mol. Biol. 2008, 267:207-252.
49. Rousseeuw P., Croux C., Todorov V., Ruckstuhl A., Salibian-Barrera M., Verbeke T., Koller M., Maechler M. Robustbase: Basic Robust Statistics. R package version 0.7-3 2011, Vienna, Austria.
50. Routledge E.J., Sumpter J.P. Estrogenic activity of surfactants and some of their degradation products assessed using a recombinant yeast screen. Environ. Toxicol. Chem. 1996, 15(3):241-248.
51. Sanseverino J., Eldridge M.L., Layton A.C., Easter J.P., Yarbrough J., Schultz T.W., Sayler G.S. Screening of potentially hormonally active chemicals using bioluminescent yeast bioreporters. Toxicol. Sci. 2009, 107(1):122-134.
52. Silva E., Rajapakse N., Kortenkamp A. Something from "nothing" - eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects. Environ. Sci. Technol. 2002, 36(8):1751-1756.
53. Silva E., Rajapakse N., Kortenkamp A. Something from "nothing" - eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects. Environ. Sci. Technol. 2002, 36(8):1751-1756.
54. Sohoni P., Sumpter J.P. Several environmental oestrogens are also anti-androgens. J. Endocrinol. 1998, 158(3):327-339.
55. Song L.N., Coghlan M., Gelmann E.P. Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor. Mol. Endocrinol. 2004, 18(1):70-85.
56. Tinwell H., Ashby J. Sensitivity of the immature rat uterotrophic assay to mixtures of estrogens. Environ. Health Perspect. 2004, 112(5):575-582.
57. van Meeuwen J.A., van den Berg M., Sanderson J.T., Verhoef A., Piersma A.H. Estrogenic effects of mixtures of phyto- and synthetic chemicals on uterine growth of prepubertal rats. Toxicol. Lett. 2007, 170(2):165-176.
58. van Ravenzwaay, B., 1992. Discussion of prenatal and reproductive toxicity of Reg. No. 83-258 (vinclozolin). Data submission to US EPA from BASF Corporation. MRID 425813-02.
59. Vinggaard A.M., Niemela J., Wedebye E.B., Jensen G.E. Screening of 397 chemicals and development of a quantitative structure-activity relationship model for androgen receptor antagonism. Chem. Res. Toxicol. 2008, 21(4):813-823.
60. Wade M.G., Foster W.G., Younglai E.V., McMahon A., Leingartner K., Yagminas A., Blakey D., Fournier M., Desaulniers D., Hughes C.L. Effects of subchronic exposure to a complex mixture of persistent contaminants in male rats: systemic, immune, and reproductive effects. Toxicol. Sci. 2002, 67(1):131-143.
61. WHO-JMPR, 1995. Vinclozolin. pp. 375-404.
62. Wilkinson C.F., Christoph G.R., Julien E., Kelley J.M., Kronenberg J., McCarthy J., Reiss R. Assessing the risks of exposures to multiple chemicals with a common mechanism of toxicity: how to cumulate?. Regul. Toxicol. Pharmacol. 2000, 31(1):30-43.
63. Wong C., Kelce W.R., Sar M., Wilson E.M. Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide. J. Biol. Chem. 1995, 270(34):19998-20003.